Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients

BACKGROUND: Low-dose metronomic chemotherapy (LDMC) is increasingly used in metastatic breast cancer (MBC). In this retrospective analysis, we examined the therapeutic effects and side effects of LDMC in a cohort of MBC patients. METHODS: Patients with MBC were included when LDMC with oral cyclophos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Care (Basel)
Autors principals: Krajnak, Slavomir, Battista, Marco, Brenner, Walburgis, Almstedt, Katrin, Elger, Tania, Heimes, Anne-Sophie, Hasenburg, Annette, Schmidt, Marcus
Format: Artigo
Idioma:Inglês
Publicat: S. Karger GmbH 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170902/
https://ncbi.nlm.nih.gov/pubmed/30319329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487629
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars